Cover Image
Market Research Report
Product code 
917680

North America Multiplex Assay Market Forecast 2019-2027

Published: | Inkwood Research | 89 Pages | Delivery time: 2-3 business days

Price

Back to Top
North America Multiplex Assay Market Forecast 2019-2027
Published: March 12, 2019
Inkwood Research
Content info: 89 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The multiplex assay market in the North American region is estimated to record a CAGR of 6.21% over the forecast period of 2019-2027. The factors leading to the growth in the market are an increase in the field of research and development for detection of various chronic diseases like cancer and cardiovascular diseases and treatment, rise in the use of personalized medicines used for increasing safety and efficiency of therapies, and benefits, such as low operational cost and reduced labor, as multiplex assays are the most economical assays.

MARKET INSIGHTS

The region of North America for the study of the multiplex assay market is divided into the US and Canada. The Canada market is dominated by the prevalence of cancer and government investments in the research and development for the discovery of drugs and treatment. As there is a steady rise in the disease in the region, the demand for multiplex assay will increase in the region as it is an important oncology tool. The huge investments by the government for the discovery and development of drugs are expected to make the market grow substantially in the region.

COMPETITIVE INSIGHTS

Some of the major companies in the market are Agilent Technologies, Inc, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc. , and Bio-Techne Corporation.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 28498

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. NUCLEIC ACID-BASED MULTIPLEX ASSAYS ARE THE FASTEST GROWING TYPE
    • 3.2.2. REAGENTS AND CONSUMABLES ARE THE WIDELY USED PRODUCTS
    • 3.2.3. MULTIPLEX PCR IS THE HIGHLY DEMANDED MULTIPLEX ASSAY TECHNOLOGY
    • 3.2.4. MULTIPLEX ASSAYS ARE HIGHLY ECONOMICAL

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. GROWING R&D ACTIVITIES & GOVERNMENTAL FUNDING
    • 4.2.2. PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
    • 4.2.3. INCREASED ADOPTION OF PERSONALIZED MEDICINES
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. LACK OF SKILLED PROFESSIONALS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. GROWING OPPORTUNITIES IN THE EMERGING ECONOMIES
    • 4.4.2. IDENTIFICATION OF NOVEL BIOMARKERS
  • 4.5. MARKET CHALLENGES
    • 4.5.1. STRINGENT REGULATIONS

5. MARKET BY TYPE

  • 5.1. PROTEIN-BASED MULTIPLEX ASSAYS
  • 5.2. NUCLEIC ACID-BASED MULTIPLEX ASSAYS
  • 5.3. OTHER MULTIPLEX ASSAYS

6. MARKET BY PRODUCT

  • 6.1. REAGENTS AND CONSUMABLES
  • 6.2. INSTRUMENTS AND ACCESSORIES
  • 6.3. SOFTWARE AND SERVICES

7. MARKET BY TECHNOLOGY

  • 7.1. MULTIPLEX PROTEIN MICROARRAY
  • 7.2. MULTIPLEX PCR
  • 7.3. OTHER TECHNOLOGY

8. MARKET BY APPLICATION

  • 8.1. CLINICAL DIAGNOSTICS
  • 8.2. RESEARCH AND DEVELOPMENT
  • 8.3. COMPANION DIAGNOSTICS

9. MARKET BY END-USER

  • 9.1. HOSPITALS
  • 9.2. CLINICAL LABORATORIES
  • 9.3. RESEARCH INSTITUTES
  • 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10. KEY ANALYTICS

  • 10.1. PORTER'S FIVE FORCES MODEL
    • 10.1.1. THREAT OF NEW ENTRANTS
    • 10.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 10.1.3. BARGAINING POWER OF BUYER
    • 10.1.4. BARGAINING POWER OF SUPPLIER
    • 10.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 10.2. KEY BUYING CRITERIA
  • 10.3. KEY TRENDS
  • 10.4. OPPORTUNITY MATRIX

11. GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1. THE UNITED STATES
    • 11.1.2. CANADA

12. COMPETITIVE LANDSCAPE

  • 12.1. MARKET SHARE ANALYSIS
  • 12.2. COMPANY PROFILES
    • 12.2.1. ABCAM PLC.
    • 12.2.2. AGILENT TECHNOLOGIES, INC.
    • 12.2.3. BECTON DICKINSON AND COMPANY
    • 12.2.4. BIO-RAD LABORATORIES, INC.
    • 12.2.5. BIO-TECHNE CORPORATION
    • 12.2.6. ILLUMINA, INC
    • 12.2.7. LUMINEX CORPORATION
    • 12.2.8. MERCK MILIPORE
    • 12.2.9. MESO SCALE DIAGNOSTICS, LLC
    • 12.2.10. OLINK PROTEOMICS AB
    • 12.2.11. QIAGEN N.V.
    • 12.2.12. RANDOX LABORATORIES LTD.
    • 12.2.13. SEEGENE INC.
    • 12.2.14. SIEMENS HEALTHINEERS
    • 12.2.15. THERMO FISHER SCIENTIFIC INC.

LIST OF TABLES

  • TABLE 1: NORTH AMERICA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • TABLE 2: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 3: NORTH AMERICA PROTEIN-BASED MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)
  • TABLE 4: NORTH AMERICA NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)
  • TABLE 5: NORTH AMERICA OTHER MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)
  • TABLE 6: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 7: NORTH AMERICA REAGENTS AND CONSUMABLES MARKET, 2019-2027 ($ MILLION)
  • TABLE 8: NORTH AMERICA INSTRUMENTS AND ACCESSORIES MARKET, 2019-2027 ($ MILLION)
  • TABLE 9: NORTH AMERICA SOFTWARE AND SERVICES MARKET, 2019-2027 ($ MILLION)
  • TABLE 10: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 11: NORTH AMERICA MULTIPLEX PROTEIN MICROARRAY MARKET, 2019-2027 ($ MILLION)
  • TABLE 12: NORTH AMERICA MULTIPLEX PCR MARKET, 2019-2027 ($ MILLION)
  • TABLE 13: NORTH AMERICA OTHER TECHNOLOGY MARKET, 2019-2027 ($ MILLION)
  • TABLE 14: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 15: NORTH AMERICA CLINICAL DIAGNOSTICS MARKET, 2019-2027 ($ MILLION)
  • TABLE 16: NORTH AMERICA RESEARCH AND DEVELOPMENT MARKET, 2019-2027 ($ MILLION)
  • TABLE 17: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, 2019-2027 ($ MILLION)
  • TABLE 18: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 19: NORTH AMERICA HOSPITALS MARKET, 2019-2027 ($ MILLION)
  • TABLE 20: NORTH AMERICA CLINICAL LABORATORIES MARKET, 2019-2027 ($ MILLION)
  • TABLE 21: NORTH AMERICA RESEARCH INSTITUTES MARKET, 2019-2027 ($ MILLION)
  • TABLE 22: NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, 2019-2027 ($ MILLION)
  • TABLE 23: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 24: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 25: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 26: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 27: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 28: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 29: CANADA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 30: CANADA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 31: CANADA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 32: CANADA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 33: CANADA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1: NORTH AMERICA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 2: NORTH AMERICA MULTIPLEX ASSAY MARKET SHARE, BY TYPE, 2018 & 2027 (%)
  • FIGURE 3: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
  • FIGURE 4: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
  • FIGURE 5: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
  • FIGURE 6: NORTH AMERICA MULTIPLEX ASSAY MARKET SHARE, BY PRODUCT, 2018 & 2027 (%)
  • FIGURE 7: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 ($ MILLION)
  • FIGURE 8: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2019-2027 ($ MILLION)
  • FIGURE 9: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2019-2027 ($ MILLION)
  • FIGURE 10: NORTH AMERICA MULTIPLEX ASSAY MARKET SHARE, BY TECHNOLOGY, 2018 & 2027 (%)
  • FIGURE 11: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2019-2027 ($ MILLION)
  • FIGURE 12: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2019-2027 ($ MILLION)
  • FIGURE 13: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
  • FIGURE 14: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGY, 2019-2027 ($ MILLION)
  • FIGURE 15: NORTH AMERICA MULTIPLEX ASSAY MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)
  • FIGURE 16: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 ($ MILLION)
  • FIGURE 17: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2019-2027 ($ MILLION)
  • FIGURE 18: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2019-2027 ($ MILLION)
  • FIGURE 19: NORTH AMERICA MULTIPLEX ASSAY MARKET SHARE, BY END-USER, 2018 & 2027 (%)
  • FIGURE 20: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2019-2027 ($ MILLION)
  • FIGURE 21: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2019-2027 ($ MILLION)
  • FIGURE 22: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)
  • FIGURE 23: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 ($ MILLION)
  • FIGURE 24: PORTER'S FIVE FORCE MODEL
  • FIGURE 25: KEY BUYING CRITERIA
  • FIGURE 26: NEWLY REGISTERED CLINICAL TRIAL STUDY 2016-2018
  • FIGURE 27: THE UNITED STATES MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 28: CANADA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 29: MULTIPLEX ASSAY COMPANY MARKET SHARE ANALYSIS 2018 (%)